Let's Break A Deal: Bad Technology A Real Liability In Healthcare M&A [Forbes]
Veradigm Inc. (MDRX)
Last veradigm inc. earnings: 3/2 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.allscripts.com
Company Research
Source: Forbes
By Claire Rychlewski As technology becomes more integral to healthcare and valuations continue to climb, the margin for error is razor-thin when it comes to assessing the health of a target company’s technology, dealmakers say. If issues are not vetted in advance of a sale process, it can result in “very significant hits to valuations, and buyers walking away,” says Amherst Partners Managing Director John Patterson, who was speaking publicly at iiBIG’s Investment and M&A Opportunities in Healthcare conference in Chicago last week. Patterson, whose firm specializes in middle-market advisory, and other panelists say that while technology has resulted in a flood of healthcare IT assets hitting the market, it has also made sale processes that much more complex. “The need for external help to assess technology has increased,” says Edward Francis, senior director in consulting firm West Monroe Partners’ Healthcare & Life Sciences practice. Buyers are working hard to
Show less
Read more
Impact Snapshot
Event Time:
MDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDRX alerts
High impacting Veradigm Inc. news events
Weekly update
A roundup of the hottest topics
MDRX
News
- Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders FoundationPR Newswire
- Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Veradigm Inc. (NASDAQ: MDRX) had its "hold" rating re-affirmed by analysts at Deutsche Bank Aktiengesellschaft. They now have a $10.00 price target on the stock, down previously from $15.00.MarketBeat
- Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor ForumBusiness Wire
- Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
MDRX
Sec Filings
- 3/15/24 - Form 4/A
- 3/15/24 - Form 3/A
- 3/13/24 - Form 8-K
- MDRX's page on the SEC website